Dudediligence.

Xenetic Biosciences, Inc

XBIONASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

2.34M

on 2026-06-30, from 1.54M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2024-10-21. Not read yet. S-3 ↗

2 of its filings are not read yet.

Warrants

800

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $29.09. 10-Q ↗

Cash

11.2 quarters

$6.5M on 2026-06-30 ÷ $578K a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-10-10Public offering735,000$6.12$4.5M424B5 ↗